Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
Identifieur interne : 001285 ( Main/Exploration ); précédent : 001284; suivant : 001286Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
Auteurs : Mandana Afsharpad [Iran] ; Sedigheh Zakeri [Iran] ; Sakineh Pirahmadi [Iran] ; Navid D. Djadid [Iran]Source :
- Infection, Genetics and Evolution [ 1567-1348 ] ; 2012-01.
English descriptors
Abstract
The increasing use of sulfadoxine/pyrimethamine (SP) for treatment of chloroquine-resistant Plasmodium falciparum has resulted in increased exposure of Plasmodium vivax parasites in areas where both species co-exist. In this study, the extent of mutations/haplotypes in pvdhfr and pvdhps was examined using PCR-RFLP methods in 427 P. vivax isolates in Iran after 4 years of introducing SP as the first-line anti-malarial drug in Iran. Mutations were detected in three codons of pvdhfr (F57L, S58R and S117N) and in one of pvdhps (A383G) and the majority of isolates had double mutations (58R/117N, 45.4%). In addition, the frequency of 57L mutation was detected in 8.2% of P. vivax isolates. This frequency was significantly increased when compared with a similar study on P. vivax isolates in 2005 (X(2) test, P<0.0001). Moreover, there was an increase in the frequency of single nucleotide polymorphisms at position 383G in pvdhps (0-2.6%) was found. Furthermore, the number of haplotypes increased from 6 to 12 in the study areas during 2006-2010. Interestingly, when combining the two loci, the frequency of parasites carrying pvdhfr/pvdhps pure mutations (L(57)R(58)/G(383), R(58)N(117)/G(383)) increased from 0% in 2006 to 2.1% in 2010. In conclusion, the present results suggest that SP could be effective in treatment against the erythrocytic stages of vivax malaria in Iran; however, the increased frequency of mutant haplotypes in Iran since 2006 is worrying and indicates the emergence of drug-tolerant/resistant P. vivax isolates in Iran in near future.
Url:
DOI: 10.1016/j.meegid.2011.10.003
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Hal, to step Corpus: 000161
- to stream Hal, to step Curation: 000161
- to stream Hal, to step Checkpoint: 000155
- to stream Main, to step Merge: 001286
- to stream Main, to step Curation: 001285
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.</title><author><name sortKey="Afsharpad, Mandana" sort="Afsharpad, Mandana" uniqKey="Afsharpad M" first="Mandana" last="Afsharpad">Mandana Afsharpad</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-55944" status="VALID"> <orgName>Institut Pasteur d'Iran</orgName> <desc> <address> <addrLine>69 avenue Pasteur Téhéran 13164</addrLine> <country key="IR"></country> </address> <ref type="url">http://www.pasteur.ac.ir/</ref> </desc> <listRelation> <relation active="#struct-301247" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName> <orgName type="acronym">RIIP</orgName> <desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine> <country key="FR"></country> </address> <ref type="url">https://research.pasteur.fr/ip-network</ref> </desc> </org></tutelle></tutelles></hal:affiliation><country>Iran</country></affiliation></author><author><name sortKey="Zakeri, Sedigheh" sort="Zakeri, Sedigheh" uniqKey="Zakeri S" first="Sedigheh" last="Zakeri">Sedigheh Zakeri</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-55944" status="VALID"> <orgName>Institut Pasteur d'Iran</orgName> <desc> <address> <addrLine>69 avenue Pasteur Téhéran 13164</addrLine> <country key="IR"></country> </address> <ref type="url">http://www.pasteur.ac.ir/</ref> </desc> <listRelation> <relation active="#struct-301247" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName> <orgName type="acronym">RIIP</orgName> <desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine> <country key="FR"></country> </address> <ref type="url">https://research.pasteur.fr/ip-network</ref> </desc> </org></tutelle></tutelles></hal:affiliation><country>Iran</country></affiliation></author><author><name sortKey="Pirahmadi, Sakineh" sort="Pirahmadi, Sakineh" uniqKey="Pirahmadi S" first="Sakineh" last="Pirahmadi">Sakineh Pirahmadi</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-55944" status="VALID"> <orgName>Institut Pasteur d'Iran</orgName> <desc> <address> <addrLine>69 avenue Pasteur Téhéran 13164</addrLine> <country key="IR"></country> </address> <ref type="url">http://www.pasteur.ac.ir/</ref> </desc> <listRelation> <relation active="#struct-301247" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName> <orgName type="acronym">RIIP</orgName> <desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine> <country key="FR"></country> </address> <ref type="url">https://research.pasteur.fr/ip-network</ref> </desc> </org></tutelle></tutelles></hal:affiliation><country>Iran</country></affiliation></author><author><name sortKey="Djadid, Navid D" sort="Djadid, Navid D" uniqKey="Djadid N" first="Navid D" last="Djadid">Navid D. Djadid</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-55944" status="VALID"> <orgName>Institut Pasteur d'Iran</orgName> <desc> <address> <addrLine>69 avenue Pasteur Téhéran 13164</addrLine> <country key="IR"></country> </address> <ref type="url">http://www.pasteur.ac.ir/</ref> </desc> <listRelation> <relation active="#struct-301247" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName> <orgName type="acronym">RIIP</orgName> <desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine> <country key="FR"></country> </address> <ref type="url">https://research.pasteur.fr/ip-network</ref> </desc> </org></tutelle></tutelles></hal:affiliation><country>Iran</country></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">HAL</idno><idno type="RBID">Hal:pasteur-00750730</idno><idno type="halId">pasteur-00750730</idno><idno type="halUri">https://hal-riip.archives-ouvertes.fr/pasteur-00750730</idno><idno type="url">https://hal-riip.archives-ouvertes.fr/pasteur-00750730</idno><idno type="doi">10.1016/j.meegid.2011.10.003</idno><date when="2012-01">2012-01</date><idno type="wicri:Area/Hal/Corpus">000161</idno><idno type="wicri:Area/Hal/Curation">000161</idno><idno type="wicri:Area/Hal/Checkpoint">000155</idno><idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000155</idno><idno type="wicri:doubleKey">1567-1348:2012:Afsharpad M:molecular:assessment:of</idno><idno type="wicri:Area/Main/Merge">001286</idno><idno type="wicri:Area/Main/Curation">001285</idno><idno type="wicri:Area/Main/Exploration">001285</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.</title><author><name sortKey="Afsharpad, Mandana" sort="Afsharpad, Mandana" uniqKey="Afsharpad M" first="Mandana" last="Afsharpad">Mandana Afsharpad</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-55944" status="VALID"> <orgName>Institut Pasteur d'Iran</orgName> <desc> <address> <addrLine>69 avenue Pasteur Téhéran 13164</addrLine> <country key="IR"></country> </address> <ref type="url">http://www.pasteur.ac.ir/</ref> </desc> <listRelation> <relation active="#struct-301247" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName> <orgName type="acronym">RIIP</orgName> <desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine> <country key="FR"></country> </address> <ref type="url">https://research.pasteur.fr/ip-network</ref> </desc> </org></tutelle></tutelles></hal:affiliation><country>Iran</country></affiliation></author><author><name sortKey="Zakeri, Sedigheh" sort="Zakeri, Sedigheh" uniqKey="Zakeri S" first="Sedigheh" last="Zakeri">Sedigheh Zakeri</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-55944" status="VALID"> <orgName>Institut Pasteur d'Iran</orgName> <desc> <address> <addrLine>69 avenue Pasteur Téhéran 13164</addrLine> <country key="IR"></country> </address> <ref type="url">http://www.pasteur.ac.ir/</ref> </desc> <listRelation> <relation active="#struct-301247" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName> <orgName type="acronym">RIIP</orgName> <desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine> <country key="FR"></country> </address> <ref type="url">https://research.pasteur.fr/ip-network</ref> </desc> </org></tutelle></tutelles></hal:affiliation><country>Iran</country></affiliation></author><author><name sortKey="Pirahmadi, Sakineh" sort="Pirahmadi, Sakineh" uniqKey="Pirahmadi S" first="Sakineh" last="Pirahmadi">Sakineh Pirahmadi</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-55944" status="VALID"> <orgName>Institut Pasteur d'Iran</orgName> <desc> <address> <addrLine>69 avenue Pasteur Téhéran 13164</addrLine> <country key="IR"></country> </address> <ref type="url">http://www.pasteur.ac.ir/</ref> </desc> <listRelation> <relation active="#struct-301247" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName> <orgName type="acronym">RIIP</orgName> <desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine> <country key="FR"></country> </address> <ref type="url">https://research.pasteur.fr/ip-network</ref> </desc> </org></tutelle></tutelles></hal:affiliation><country>Iran</country></affiliation></author><author><name sortKey="Djadid, Navid D" sort="Djadid, Navid D" uniqKey="Djadid N" first="Navid D" last="Djadid">Navid D. Djadid</name><affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-55944" status="VALID"> <orgName>Institut Pasteur d'Iran</orgName> <desc> <address> <addrLine>69 avenue Pasteur Téhéran 13164</addrLine> <country key="IR"></country> </address> <ref type="url">http://www.pasteur.ac.ir/</ref> </desc> <listRelation> <relation active="#struct-301247" type="direct"></relation> </listRelation> <tutelles><tutelle active="#struct-301247" type="direct"><org type="regroupinstitution" xml:id="struct-301247" status="VALID"> <orgName>Réseau International des Instituts Pasteur</orgName> <orgName type="acronym">RIIP</orgName> <desc> <address> <addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine> <country key="FR"></country> </address> <ref type="url">https://research.pasteur.fr/ip-network</ref> </desc> </org></tutelle></tutelles></hal:affiliation><country>Iran</country></affiliation></author></analytic><idno type="DOI">10.1016/j.meegid.2011.10.003</idno><series><title level="j">Infection, Genetics and Evolution</title><idno type="ISSN">1567-1348</idno><imprint><date type="datePub">2012-01</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="mix" xml:lang="en"><term>Haplotype</term><term>Mutations</term><term>Plasmodium vivax</term><term>Sulfadoxine-pyrimethamine (SP)</term><term>pvdhfr</term><term>pvdhps</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"> <p>The increasing use of sulfadoxine/pyrimethamine (SP) for treatment of chloroquine-resistant Plasmodium falciparum has resulted in increased exposure of Plasmodium vivax parasites in areas where both species co-exist. In this study, the extent of mutations/haplotypes in pvdhfr and pvdhps was examined using PCR-RFLP methods in 427 P. vivax isolates in Iran after 4 years of introducing SP as the first-line anti-malarial drug in Iran. Mutations were detected in three codons of pvdhfr (F57L, S58R and S117N) and in one of pvdhps (A383G) and the majority of isolates had double mutations (58R/117N, 45.4%). In addition, the frequency of 57L mutation was detected in 8.2% of P. vivax isolates. This frequency was significantly increased when compared with a similar study on P. vivax isolates in 2005 (X(2) test, P<0.0001). Moreover, there was an increase in the frequency of single nucleotide polymorphisms at position 383G in pvdhps (0-2.6%) was found. Furthermore, the number of haplotypes increased from 6 to 12 in the study areas during 2006-2010. Interestingly, when combining the two loci, the frequency of parasites carrying pvdhfr/pvdhps pure mutations (L(57)R(58)/G(383), R(58)N(117)/G(383)) increased from 0% in 2006 to 2.1% in 2010. In conclusion, the present results suggest that SP could be effective in treatment against the erythrocytic stages of vivax malaria in Iran; however, the increased frequency of mutant haplotypes in Iran since 2006 is worrying and indicates the emergence of drug-tolerant/resistant P. vivax isolates in Iran in near future.</p> </div></front></TEI><affiliations><list><country><li>Iran</li></country></list><tree><country name="Iran"><noRegion><name sortKey="Afsharpad, Mandana" sort="Afsharpad, Mandana" uniqKey="Afsharpad M" first="Mandana" last="Afsharpad">Mandana Afsharpad</name></noRegion><name sortKey="Djadid, Navid D" sort="Djadid, Navid D" uniqKey="Djadid N" first="Navid D" last="Djadid">Navid D. Djadid</name><name sortKey="Pirahmadi, Sakineh" sort="Pirahmadi, Sakineh" uniqKey="Pirahmadi S" first="Sakineh" last="Pirahmadi">Sakineh Pirahmadi</name><name sortKey="Zakeri, Sedigheh" sort="Zakeri, Sedigheh" uniqKey="Zakeri S" first="Sedigheh" last="Zakeri">Sedigheh Zakeri</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001285 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001285 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Hal:pasteur-00750730
|texte= Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
}}
| This area was generated with Dilib version V0.6.33. |  |